Quoin Pharmaceuticals Ltd Adr (QNRX)

Aug 27, 2025

Quoin Pharmaceuticals finalizes separation agreement with former CFO - Investing.com

Aug 27, 2025

Aug 26, 2025

Quoin Pharmaceuticals (NASDAQ:QNRX) Shares Up 2.8% – Still a Buy? - Defense World

Aug 26, 2025

Aug 09, 2025

Analysts Offer Insights on Healthcare Companies: Myomo (MYO), Quoin Pharmaceuticals (QNRX) and RegenXBio (RGNX) - The Globe and Mail

Aug 09, 2025

Aug 08, 2025

Quoin (QNRX) Q2 Loss Beats Estimates - The Motley Fool

Aug 08, 2025

Jul 31, 2025

Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - The Globe and Mail

Jul 31, 2025

Jul 30, 2025

Quoin Pharmaceuticals stock rises after positive clinical updates - Investing.com India

Jul 30, 2025

Jul 29, 2025

Quoin Pharmaceuticals advances rare disease pipeline with two active trials - Investing.com India

Jul 29, 2025

Jul 29, 2025

Quoin Pharmaceuticals advances rare disease pipeline with two active trials By Investing.com - Investing.com Nigeria

Jul 29, 2025

Jul 26, 2025

Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Price Down 2.9% – Here’s Why - Defense World

Jul 26, 2025

Jul 26, 2025

MINISO Group Holding Limited Unsponsored ADR (NYSE:MNSO) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jul 26, 2025

Jul 09, 2025

Quoin Pharmaceuticals CFO Gordon Dunn to depart following mutual agreement - Investing.com India

Jul 09, 2025

Jul 04, 2025

Quoin Pharmaceuticals (NASDAQ:QNRX) Trading Down 1.2% – Should You Sell? - Defense World

Jul 04, 2025

Jun 25, 2025

Quoin Pharmaceuticals receives FDA rare pediatric disease designation for QRX003 - Investing.com

Jun 25, 2025

Jun 24, 2025

FDA grants rare pediatric disease designation for Netherton syndrome drug - Investing.com

Jun 24, 2025

May 22, 2025

Quoin announces FDA clearance to initiate second whole body QRX003 NS study - TipRanks

May 22, 2025

May 22, 2025

FDA clears Quoin’s new Netherton syndrome study By Investing.com - Investing.com South Africa

May 22, 2025

May 22, 2025

FDA clears Quoin’s new Netherton syndrome study - Investing.com

May 22, 2025

May 20, 2025

Quoin Pharmaceuticals announces EMA grants ODD for QRX003 - TipRanks

May 20, 2025

May 14, 2025

Retail Buzz Intensifies Around Quoin Pharma Stock After Positive Pediatric Skin Study Data By Stocktwits - Investing.com India

May 14, 2025

May 14, 2025

Why Quoin Pharmaceuticals (QNRX) Stock Is Exploding Higher Wednesday - Benzinga

May 14, 2025

May 14, 2025

Quoin Pharmaceuticals announces initial positive clinical data for QRX003 - TipRanks

May 14, 2025

May 14, 2025

Quoin reports progress in pediatric skin disorder study By Investing.com - Investing.com India

May 14, 2025

May 13, 2025

Quoin Pharmaceuticals reports Q1 EPS ($6.50) vs ($38.73) last year - TipRanks

May 13, 2025

May 01, 2025

Quoin Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com India

May 01, 2025

Apr 30, 2025

Quoin Pharmaceuticals regains Nasdaq compliance - Investing.com

Apr 30, 2025

Apr 30, 2025

Quoin Pharmaceuticals regains compliance with Nasdaq minimum bid price rule - TipRanks

Apr 30, 2025

Apr 30, 2025

Quoin Pharmaceuticals regains Nasdaq compliance with bid price - Investing.com

Apr 30, 2025

Apr 10, 2025

Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series - TipRanks

Apr 10, 2025

Apr 07, 2025

QNRX Stock Plummets to 52-Week Low of $0.17 Amid Market Struggles - Investing.com India

Apr 07, 2025

Apr 07, 2025

Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested - markets.businessinsider.com

Apr 07, 2025

Apr 04, 2025

Quoin Pharmaceuticals announces ADS ratio change to meet Nasdaq requirements By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

Quoin Pharmaceuticals announces ADS ratio change to meet Nasdaq requirements - Investing.com

Apr 04, 2025

Apr 02, 2025

Quoin Pharmaceuticals reports positive clinical data for rare disease treatment - Investing.com India

Apr 02, 2025

Apr 02, 2025

Quoin Pharmaceuticals reports positive clinical data for rare disease treatment By Investing.com - Investing.com South Africa

Apr 02, 2025

Mar 31, 2025

What Is Going On With Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX)? - stocksregister.com

Mar 31, 2025

Mar 28, 2025

QNRX Stock Plummets to 52-Week Low at $0.26 Amid Market Struggles By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

QNRX Stock Plummets to 52-Week Low at $0.26 Amid Market Struggles - Investing.com India

Mar 28, 2025

Mar 25, 2025

Quoin seeks patent for skin disease treatment QRX003 By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

Quoin seeks patent for skin disease treatment QRX003 - Investing.com India

Mar 25, 2025

Mar 04, 2025

QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles - Investing.com India

Mar 04, 2025

Mar 04, 2025

QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles By Investing.com - Investing.com South Africa

Mar 04, 2025

Mar 02, 2025

NVIDIA Corp (NVDA) Shares Up Despite Recent Market Volatility - The News Heater

Mar 02, 2025

Feb 27, 2025

Quoin Pharmaceuticals reports promising Netherton Syndrome treatment - Investing.com

Feb 27, 2025

Feb 04, 2025

Quoin Pharmaceuticals launches Netherton awareness campaign - Investing.com

Feb 04, 2025

Jan 31, 2025

Earnings call transcript: Quoin Pharmaceuticals Q4 2023 sees stock volatility - Investing.com

Jan 31, 2025

Jan 06, 2025

Quoin reports positive results in Netherton Syndrome study - Investing.com

Jan 06, 2025

Dec 27, 2024

Quoin Pharmaceuticals CEO Michael Myers acquires $250,000 in shares - Investing.com

Dec 27, 2024

Oct 31, 2024

Quoin Pharmaceuticals granted extension to meet Nasdaq listing - Investing.com

Oct 31, 2024

Sep 05, 2024

Quoin Pharmaceuticals COO acquires $28,737 in company shares - Investing.com

Sep 05, 2024

Apr 24, 2024

Zacks Small Cap Research Equity Research & Stock Reports - Research Tree

Apr 24, 2024